| Fox Valley Nephrology Partners S C | |
|
300 N Commercial St 200 Neenah WI 54956-2619 | |
| (920) 886-0818 | |
| (920) 886-0773 |
| Full Name | Fox Valley Nephrology Partners S C |
|---|---|
| Speciality | Clinic/Center |
| Location | 300 N Commercial St, Neenah, Wisconsin |
| Authorized Official Name and Position | Faith L Keefer (BILLING) |
| Authorized Official Contact | 9208860818 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Fox Valley Nephrology Partners S C 300 N Commercial St 200 Neenah WI 54956-2619 Ph: (920) 886-0818 | Fox Valley Nephrology Partners S C 300 N Commercial St 200 Neenah WI 54956-2619 Ph: (920) 886-0818 |
| NPI Number | 1891713756 |
|---|---|
| Provider Enumeration Date | 07/18/2006 |
| Last Update Date | 10/06/2022 |
| Medicare PECOS PAC ID | 3870559404 |
|---|---|
| Medicare Enrollment ID | O20041206000889 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891713756 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (* (Not Available)) | Primary |
| Provider Name | David W Koeper |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1487698387 PECOS PAC ID: 9234030206 Enrollment ID: I20040114000425 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Kay L Conradt |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1316989056 PECOS PAC ID: 5294627295 Enrollment ID: I20040325001130 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Atif A Qureshi |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1629014790 PECOS PAC ID: 5597726489 Enrollment ID: I20041025000028 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Osaid K Ahmad |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1689618589 PECOS PAC ID: 1658306980 Enrollment ID: I20051005000491 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Rachel A Koeper |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1174581862 PECOS PAC ID: 3870631088 Enrollment ID: I20091109000567 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Courtney R Beaudette |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1750679114 PECOS PAC ID: 3274702907 Enrollment ID: I20110812000554 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Nicole M Becher |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1164976874 PECOS PAC ID: 3577858695 Enrollment ID: I20160829000042 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Syed A Shah |
|---|---|
| Provider Type | Practitioner - Hospitalist |
| Provider Identifiers | NPI Number: 1447485784 PECOS PAC ID: 4880842764 Enrollment ID: I20161018000664 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Imran A Baloch |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1659399822 PECOS PAC ID: 0648270124 Enrollment ID: I20170817002901 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Asad Majid |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1982778254 PECOS PAC ID: 0749278109 Enrollment ID: I20200715001551 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Laura M Stafford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1245848423 PECOS PAC ID: 4284050360 Enrollment ID: I20200819003757 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Jessica Dominguez |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1225649973 PECOS PAC ID: 0749607737 Enrollment ID: I20200908000749 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | John S Thurlow |
|---|---|
| Provider Type | Practitioner - Nephrology |
| Provider Identifiers | NPI Number: 1740441237 PECOS PAC ID: 3375958739 Enrollment ID: I20210216003243 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Amber M Demerath |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1356072417 PECOS PAC ID: 3971986431 Enrollment ID: I20220816001171 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
| Provider Name | Nicole A Nguyen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1609574573 PECOS PAC ID: 2860866654 Enrollment ID: I20230317001057 |
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
News Archive
In colorectal cancer, the presence of invasive tumor cells at the advancing edge of the tumor can provide valuable information on prognosis. Initiated by the Colorectal Cancer Research Group at the Institute of Pathology, University of Bern, a consensus conference was held to determine how this phenomenon should best be put into practice.
By tagging a cell's proteins with fluorescent beacons, Cornell researchers have found out how E. coli bacteria defend themselves against antibiotics and other poisons. Probably not good news for the bacteria.
With five years and $25M invested in R&D, in partnership with industry leading manufacturers (Sirona, Meisinger, SycoTec - R&D spin off of KaVo), ProDrive Systems today announced the launch of ProDrive products nationwide in Canada with an exclusive multimillion-dollar agreement through Patterson Dental Canada.
A team led by scientists at The Scripps Research Institute and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.
A new study of more than 1,000 primary care melanoma screenings in the western Pennsylvania area in 2014 suggests that overall the practice complies with the old medical maxim to "first do no harm."
› Verified 8 days ago
Affinity Health System Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 411 Lincoln St, Neenah, WI 54956 Phone: 920-727-4347 | |
Ascension Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 740 Deerwood Ave, Neenah, WI 54956 Phone: 920-751-9600 | |
St Vincent Hospital-hospital Sisters-third Order Of St Francis Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 600 Elm St, Neenah, WI 54956 Phone: 920-496-4700 | |
Gastrointestinal Specialists Sc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 130 2nd St, Suite N157, Neenah, WI 54956 Phone: 920-426-2211 Fax: 920-426-2231 | |
Ascension Medical Group Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 101 Main St, Neenah, WI 54956 Phone: 920-727-4200 | |
Premier Health S.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1540 Lyon Dr, Neenah, WI 54956 Phone: 920-727-4946 Fax: 920-727-4956 | |
Life Wellness Center - Neenah Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 7273 State Road 76, Neenah, WI 54956 Phone: 920-727-7599 Fax: 888-892-0604 |